Literature DB >> 32354923

Comparison of HPV Testing and Colposcopy in Detecting Cervical Dysplasia in Patients With Cytological Abnormalities.

Joanna Świderska-Kiec1, Krzysztof Czajkowski1, Julia Zaręba-Szczudlik2, Joanna Kacperczyk-Bartnik1, Paweł Bartnik1, Ewa Romejko-Wolniewicz1.   

Abstract

AIM: The aim of the study was to compare the diagnostic value of HPV testing and colposcopy in patients with abnormal cytology results. PATIENTS AND METHODS: A total of 186 women with cytological abnormalities were included in the study. The patients underwent colposcopy examinations and DNA HPV testing of cervical smear with genotyping.
RESULTS: The HPV test was demonstrated to be more sensitive (79.4%) than specific (60.2%) and was more sensitive than colposcopy for detecting CIN changes (79.4% vs. 73.7%). Combined tests achieved a high sensitivity (90.9%) and negative predictive value (96.1%) in detecting patients with CIN2+ and demonstrated the highest positive predictive value (77.3%) for detecting CIN1+. Colposcopy had a very good specificity (83.5%) and positive predictive value (71.2%) in finding CIN1+ cases.
CONCLUSION: HPV tests showed a higher sensitivity than colposcopy, but colposcopy results presented higher specificity. Combining HPV testing and colposcopy proved to be the most efficient method for detecting CIN lesions. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cervical intraepithelial neoplasia; colposcopy; diagnosis; papillomaviridae

Mesh:

Substances:

Year:  2020        PMID: 32354923      PMCID: PMC7279809          DOI: 10.21873/invivo.11906

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  37 in total

1.  Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.

Authors:  Maria Adamopoulou; Eleni Kalkani; Ekatherina Charvalos; Dimitris Avgoustidis; Dimitris Haidopoulos; Christos Yapijakis
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

2.  Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.

Authors:  Mark F Evans; Christine S-C Adamson; Jacalyn L Papillo; Timothy L St John; Gladwyn Leiman; Kumarasen Cooper
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

Review 3.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.

Authors:  Gary Clifford; Silvia Franceschi; Mireia Diaz; Nubia Muñoz; Luisa Lina Villa
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

4.  Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.

Authors:  Paolo Giorgi Rossi; Simonetta Bisanzi; Irene Paganini; Angela Di Iasi; Claudio Angeloni; Aurora Scalisi; Rosalba Macis; Maria Teresa Pini; Francesco Chini; Francesca Maria Carozzi
Journal:  BMC Infect Dis       Date:  2010-07-20       Impact factor: 3.090

Review 5.  Overview of recurrent respiratory papillomatosis.

Authors:  Brian J Wiatrak
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2003-12       Impact factor: 2.064

6.  HPV detection in cervical cancer patients in northern Poland.

Authors:  Aleksandra Dybikowska; Pawel Licznerski; Anna Podhajska
Journal:  Oncol Rep       Date:  2002 Jul-Aug       Impact factor: 3.906

7.  Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.

Authors:  André Luis Santos; Sophie Françoise Derchain; Marcos Roberto Martins; Luís Otávio Sarian; Edson Zangiacome Martinez; Kari Juhani Syrjänen
Journal:  Sao Paulo Med J       Date:  2004-06-28       Impact factor: 1.044

8.  Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types.

Authors:  Stefano Menzo; Andrea Ciavattini; Patrizia Bagnarelli; Katia Marinelli; Stefano Sisti; Massimo Clementi
Journal:  BMC Microbiol       Date:  2008-07-04       Impact factor: 3.605

9.  Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand.

Authors:  Jie-Bin Lew; Kate Simms; Megan Smith; Hazel Lewis; Harold Neal; Karen Canfell
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

10.  Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions.

Authors:  Mert Ulaş Barut; Ahmet Kale; Umur Kuyumcuoğlu; Murat Bozkurt; Elif Ağaçayak; Server Özekinci; Talip Gül
Journal:  Med Sci Monit       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.